Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
KG > SEC Filings for KG > Form 8-K on 27-Mar-2009All Recent SEC Filings

Show all filings for KING PHARMACEUTICALS INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for KING PHARMACEUTICALS INC


27-Mar-2009

Change in Directors or Principal Officers


Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 23, 2009, the Compensation and Human Resources Committee (the "Committee") of the Board of Directors of King Pharmaceuticals, Inc. ("King") approved the 2009 Executive Management Incentive Awards program (the "2009 EMIA"), which defines the parameters under which certain executives of King will be eligible to receive cash awards related to performance during 2009.
Under the 2009 EMIA, adopted pursuant to the King Pharmaceuticals, Inc. Incentive Plan, awards to executive officers (as defined by the Securities Exchange Act of 1934 and referred to in this document as "Executive Officers") and other executives who report to the Chief Executive Officer will be based upon accomplishment of one or more financial objectives ("Financial Objectives"). Awards to other EMIA Participants (as defined below) will also be based upon accomplishment of Financial Objectives.
Executives having the title of Vice President or a more senior title as of January 1, 2009 are eligible to participate in the 2009 EMIA, including all Executive Officers (each such person being an "EMIA Participant"). The Committee may establish an EMIA for other persons who become Executive Officers after January 1, 2009, and the Chief Executive Officer may establish an EMIA for other persons who become EMIA participants after January 1, 2009, in each case subject to certain limitations.
Under the terms of the 2009 EMIA, the Committee has established and approved all Financial Objectives and must approve any amendments to those objectives. The Committee has also approved the specific weighting of the Financial Objectives for the Executive Officers and must approve any amendments thereto. Potential EMIA awards for Executive Officers are based upon prospective financial goals, the accomplishment of which was substantially uncertain at the time of their establishment.
Payment of any 2009 EMIA award is contingent upon the Committee's determination that the applicable Financial Objectives have been met, and at what achievement level those objectives have been met. In addition, in order to receive a 2009 EMIA award, the EMIA Participant must continue to be employed by King on December 31, 2009, except in the case of death, incapacity, disability or approved retirement.
The Committee, in its discretion, may reduce or eliminate any EMIA award if it determines such action to be in the best interests of King. The Committee may also, at any time, amend or terminate the 2009 EMIA program.


  Add KG to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for KG - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.